Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3274668 | 0.74 | TAAR1 (0.33) | — | |
| SCHEMBL17698457 | 0.74 | ORAI1 (0.36) | KDM4EALDH1A1 | |
| SCHEMBL3274039 | 0.66 | TAAR1 (0.38) | KDM4EALDH1A1 | |
| SCHEMBL21757942 | 0.65 | ORAI1 (0.41) | — | |
| SCHEMBL3275714 | 0.65 | TRPV6 (0.70) | — | |
| SCHEMBL16720604 | 0.64 | CHRNA7 (0.46) | KDM4EALDH1A1 | |
| SCHEMBL17698461 | 0.63 | ORAI1 (0.36) | KDM4EALDH1A1 | |
| Trimethylammonium SCHEMBL27796925 | 0.62 | ALDH1A1 (0.47) | KDM4EALDH1A1 | |
| SCHEMBL10454943 | 0.62 | SLC6A2 (0.41) | KDM4EALDH1A1 | |
| SCHEMBL16760880 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100087645-A1 | NOVEL BISBORON COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-08 | — | — | US | claimed |
| US-20100087645-A1 | NOVEL BISBORON COMPOUND | JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) | 2010-04-08 | — | — | US | disclosed |
| EP-1961756-A1 | NOVEL BISBORON COMPOUND | Japan Science and Technology Agency (JP) | 2008-08-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100087645-A1 | NOVEL BISBORON COMPOUND | KCNMB4, CA2, NR0B2 | KDM4E 3037/4885ALDH1A1 4802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.